Literature DB >> 12536148

Tau phosphorylation by cyclin-dependent kinase 5/p39 during brain development reduces its affinity for microtubules.

Satoru Takahashi1, Taro Saito, Shin-ichi Hisanaga, Harish C Pant, Ashok B Kulkarni.   

Abstract

The microtubule-associated protein tau is a developmentally regulated neuronal phosphoprotein. The phosphorylation of tau reduces its ability to bind and stabilize axonal microtubules during axonal growth. Although tau is phosphorylated by cyclin-dependent kinase 5 (Cdk5) in vitro, its in vivo roles remain unclear. Here, we show that tau is phosphorylated by Cdk5/p39 during brain development, resulting in a reduction of its affinity for microtubules. The activity of Cdk5 is tightly regulated by association with its neuronal activators, p35 or p39. The p35 and p39 expression levels were investigated in the developing mouse brain; the p39 expression level was higher in embryonic hind brain and spinal cord and in postnatal cerebral cortex, whereas that of p35 was most prominent in cerebral cortex at earlier stages of development. The ability of Cdk5 to phosphorylate tau was higher when in association with p39 than in association with p35. Tau phosphorylation at Ser-202 and Thr-205 was decreased in Cdk5-/- mouse brain but not in p35-/- mouse brain, suggesting that Cdk5/p39 is responsible for the in vivo phosphorylation of tau at these sites. Our data suggest that tau phosphorylation by Cdk5 may provide the neuronal microtubules with dynamic properties in a region-specific and developmentally regulated manner.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12536148     DOI: 10.1074/jbc.M211964200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  27 in total

1.  Role for neuronal insulin resistance in neurodegenerative diseases.

Authors:  Markus Schubert; Dinesh Gautam; David Surjo; Kojihiko Ueki; Stephanie Baudler; Dominic Schubert; Tatsuya Kondo; Jens Alber; Norbert Galldiks; Eckehardt Küstermann; Saskia Arndt; Andreas H Jacobs; Wilhelm Krone; C Ronald Kahn; Jens C Brüning
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-23       Impact factor: 11.205

2.  The CDK5 activator, p39, binds specifically to myosin essential light chain.

Authors:  Dolena R Ledee; Brajendra K Tripathi; Peggy S Zelenka
Journal:  Biochem Biophys Res Commun       Date:  2007-01-29       Impact factor: 3.575

3.  Inhibition of cyclin-dependent kinase 5 but not of glycogen synthase kinase 3-β prevents neurite retraction and tau hyperphosphorylation caused by secretable products of human T-cell leukemia virus type I-infected lymphocytes.

Authors:  Horacio Maldonado; Eugenio Ramírez; Elias Utreras; María E Pando; Ana M Kettlun; Mario Chiong; Ashok B Kulkarni; Lucía Collados; Javier Puente; Luis Cartier; María A Valenzuela
Journal:  J Neurosci Res       Date:  2011-06-10       Impact factor: 4.164

4.  Special Issue on "Cdk5 and Brain Disorders": Prologue.

Authors:  Jyotshnabala Kanungo
Journal:  Brain Disord Ther       Date:  2012-05-31

5.  The Cdk5 activator P39 specifically links muskelin to myosin II and regulates stress fiber formation and actin organization in lens.

Authors:  Brajendra K Tripathi; Douglas R Lowy; Peggy S Zelenka
Journal:  Exp Cell Res       Date:  2014-08-13       Impact factor: 3.905

6.  Regulation of mitochondrial transport and inter-microtubule spacing by tau phosphorylation at the sites hyperphosphorylated in Alzheimer's disease.

Authors:  Kourosh Shahpasand; Isao Uemura; Taro Saito; Tsunaki Asano; Kenji Hata; Keitaro Shibata; Yoko Toyoshima; Masato Hasegawa; Shin-Ichi Hisanaga
Journal:  J Neurosci       Date:  2012-02-15       Impact factor: 6.167

7.  Increased activity of cyclin-dependent kinase 5 leads to attenuation of cocaine-mediated dopamine signaling.

Authors:  Satoru Takahashi; Toshio Ohshima; Andrew Cho; Taduru Sreenath; Michael J Iadarola; Harish C Pant; Yong Kim; Angus C Nairn; Roscoe O Brady; Paul Greengard; Ashok B Kulkarni
Journal:  Proc Natl Acad Sci U S A       Date:  2005-01-21       Impact factor: 11.205

8.  Correlation between semaphorin3A-induced facilitation of axonal transport and local activation of a translation initiation factor eukaryotic translation initiation factor 4E.

Authors:  Chanxia Li; Yukio Sasaki; Kohtaro Takei; Hiroshi Yamamoto; Masayuki Shouji; Yoshinobu Sugiyama; Tadashi Kawakami; Fumio Nakamura; Takeshi Yagi; Toshio Ohshima; Yoshio Goshima
Journal:  J Neurosci       Date:  2004-07-07       Impact factor: 6.167

9.  Conditional deletion of neuronal cyclin-dependent kinase 5 in developing forebrain results in microglial activation and neurodegeneration.

Authors:  Satoru Takahashi; Toshio Ohshima; Motoyuki Hirasawa; Tej K Pareek; Thomas H Bugge; Alexei Morozov; Kenji Fujieda; Roscoe O Brady; Ashok B Kulkarni
Journal:  Am J Pathol       Date:  2009-11-30       Impact factor: 4.307

10.  Targeting Cdk5 activity in neuronal degeneration and regeneration.

Authors:  Jyotshnabala Kanungo; Ya-li Zheng; Niranjana D Amin; Harish C Pant
Journal:  Cell Mol Neurobiol       Date:  2009-12       Impact factor: 5.046

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.